Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction

Cites (239)

Items 201–239 of 239

1. State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 – Relation to antipsychotic-like drug effects
   Robert W. Gould, Michael T. Nedelcovych, Xuewen Gong, Erica Tsai, Michael Bubser, Thomas M. Bridges, Michael R. Wood, Mark E. Duggan, Nicholas J. Brandon, John Dunlop et al. · 2015 · Neuropharmacology
2. Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
   Angeliki Zarkali, Andrea I. Luppi, Emmanuel Andreas Stamatakis, Suzanne Reeves, Peter McColgan, Louise‐Ann Leyland, Andrew John Lees, Rimona Sharon Weil · 2022 · Communications Biology
3. Structure and function of dual‐source cholinergic modulation in early vision
   Juliane Krueger, Anita A. Disney · 2018 · The Journal of Comparative Neurology
4. Hypersensitivity of cortical muscarinic receptors in Parkinson's disease demonstrated by PET
   Masato Asahina, Hitoshi Shinotoh, Keizo Hirayama, Tetsuya Suhara, F. Shishido, Osamu Inoue, Yukio Tateno · 2009 · Acta Neurologica Scandinavica
5. Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease
   Zarkali, Angeliki, McColgan, Peter, Leyland, Louise Ann, Lees, Andrew John, Weil, Rimona Sharon · 2022 · Journal of Neurology, Neurosurgery & Psychiatry
6. Intermittent stimulation in the nucleus basalis of meynert improves sustained attention in rhesus monkeys
   Ruifeng Liu, Jonathan Crawford, Patrick M. Callahan, Alvin V. Terry, Christos Constantinidis, David T. Blake · 2018 · Neuropharmacology
7. Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia
   Elie Matar, Kaylena A. Ehgoetz Martens, Joseph R. Phillips, Gabriel Wainstein, Glenda Margaret Halliday, Simon J.G. Lewis, James M. Shine · 2022 · npj Parkinson s Disease
8. Abnormal higher-order network interactions in Parkinson’s disease visual hallucinations
   Joshua B. Tan, Eli J. Müller, Isabella F Orlando, Natasha L. Taylor, Daniel S. Margulies, Jennifer Y. Y. Szeto, Simon J.G. Lewis, James M. Shine, Claire O’Callaghan · 2023 · Brain
9. Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071
   Aaron J. Kucinski, Kyra B. Phillips, Ajeesh Koshy Cherian, Martin F. Sarter · 2019 · Psychopharmacology
10. Nicotinicα4β2acetylcholine receptors and cognitive function in Parkinson's disease
    Reinhard Lorenz, Samuel Samnick, Ulrich Dillmann, Markus Schiller, M.F. Ong, Klaus C Fassbender, Andreas Konrad Buck, Jörg Spiegel · 2014 · Acta Neurologica Scandinavica
11. Moving from phenomenological to predictive modelling: Progress and pitfalls of modelling brain stimulation in-silico
    Danielle L. Kurtin, Valentina Giunchiglia, Jakub Vohryzek, Joana Cabral, Anne C. Skeldon, Inês R. Violante · 2023 · NeuroImage
12. Patient-specific models link neurotransmitter receptor mechanisms with motor and visuospatial axes of Parkinson’s disease
    Khan, Ahmed Faraz, Adewale, Quadri, Lin, Sue-Jin, Baumeister, Tobias R., Zeighami, Yashar, Carbonell, Felix, Palomero-Gallagher, Nicola, Iturria-Medina, Yasser · 2023 · Nature Communications
13. Night‐time hypnopompic visual hallucinations related to REM sleep disorder
    Kokichi Takata, Yuichi Inoue, Hidebumi Hazama, Etsuo Fukuma · 1998 · Psychiatry and Clinical Neurosciences
14. Changes in structural network topology correlate with severity of hallucinatory behavior in Parkinson’s disease
    Julie M. Hall, Claire O’Callaghan, Alana J. Muller, Kaylena A. Ehgoetz Martens, Joseph R. Phillips, Ahmed A. Moustafa, Simon J.G. Lewis, James M. Shine · 2019 · Network Neuroscience
15. Theta oscillations and minor hallucinations in Parkinson’s disease reveal decrease in frontal lobe functions and later cognitive decline
    Fosco Bernasconi, Javier Pagonabarraga, Helena Bejr‐Kasem, Saül Martínez‐Horta, Juan Marín‐Lahoz, Andrea Horta‐Barba, Jaime Kulisevsky, Olaf Blanke · 2023 · Nature Mental Health
16. Altered Nucleus Basalis Connectivity Predicts Treatment Response in Mild Cognitive Impairment
    Dewen Meng, Xingfeng Li, Markus Bauer, John‐Paul Taylor, Dorothee P. Auer, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Radiology
17. Cholinergic Modulation Promotes Attentional Modulation in Primary Visual Cortex- A Modeling Study
    Atena Sajedin, Mohammad Bagher Menhaj, Abdol‐Hossein Vahabie, Stefano Panzeri, Hossein Esteky · 2019 · Scientific Reports
18. Hallucinations and Development of Dementia in Parkinson’s Disease
    Wojciech Gryc, K Roberts, Cyrus P. Zabetian, Daniel A. Weintraub, John Q. Trojanowski, Joseph F. Quinn, Amie Hiller, Kathryn A. Chung, Kathleen L. Poston, Laurice Yang et al. · 2020 · Journal of Parkinson s Disease
19. Cumulative latency advance underlies fast visual processing in desynchronized brain state
    Xudong Wang, Chen Cheng, Dinghong Zhang, Haishan Yao · 2013 · Proceedings of the National Academy of Sciences
20. Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study
    Meenakshi Dauwan, Jorrit I. Hoff, E.M. Vriens, Arjan Hillebrand, Cornelis Jan Stam, Iris E. Sommer · 2019 · NeuroImage Clinical
21. The effects of rivastigmine on neuropsychiatric symptoms in the early stages of Parkinson's disease: A systematic review
    Siobhan Reilly, Simran Dhaliwal, Usman Arshad, Antonella Macerollo, Nusrat Husain, Antonio Da Costa · 2023 · European Journal of Neurology
22. Synapse Density Related to Cerebral Blood Flow and Symptomatology in Frontal Lobe Degeneration and Alzheimer’s Disease
    Xiaoying Liu, Ulla Passant, Jarl Risberg, Siegbert Warkentin, Arne E. Brun · 1999 · Dementia and Geriatric Cognitive Disorders
23. Differential Role of Muscarinic Transmission within the Entorhinal Cortex and Basolateral Amygdala in the Processing of Irrelevant Stimuli
    Segev Barak, Ina Weiner · 2010 · Neuropsychopharmacology
24. T‐495, a novel low cooperative M1 receptor positive allosteric modulator, improves memory deficits associated with cholinergic dysfunction and is characterized by low gastrointestinal side effect risk
    Takao Mandai, Yuu Sako, Emi Kurimoto, Yūji Shimizu, Minoru Nakamura, Makoto Fushimi, Ryouta Maeda, Maki Miyamoto, Haruhide Kimura · 2020 · Pharmacology Research & Perspectives
25. Limbic thalamus atrophy is associated with visual hallucinations in Lewy body disorders
    Elie Matar, Daniel Brooks, Simon J.G. Lewis, Glenda Margaret Halliday · 2022 · Neurobiology of Aging
26. Long-Term Effect of Acetylcholinesterase Inhibitors on the Dorsal Attention Network of Alzheimer’s Disease Patients: A Pilot Study Using Resting-State Functional Magnetic Resonance Imaging
    Kenichiro Yamashita, Taira Uehara, Yoshihide Taniwaki, Shozo Tobimatsu, Jun‐ichi Kira · 2022 · Frontiers in Aging Neuroscience
27. Cholinergic muscarinic M1/M4 receptor networks in dementia with Lewy bodies
    Sean J. Colloby, Pradeep J. Nathan, Ian Grant McKeith, Geor Bakker, John Tiernan O'Brien, John‐Paul Taylor · 2020 · Brain Communications
28. Spatial Covariance of Cholinergic Muscarinic M1 / M4 Receptors in Parkinson's Disease
    Sean J. Colloby, Pradeep J. Nathan, Geor Bakker, Rachael Ashleigh Lawson, Alison Jane Yarnall, David John Burn, John Tiernan O'Brien, John‐Paul Taylor · 2021 · Movement Disorders
29. Visual Memory Errors in Parkinson's Disease Patient With Visual Hallucinations
    James Barnes, Laura Boubert · 2010 · International Journal of Neuroscience
30. The role of the thalamic reticular nucleus in visual processing
    Adam Murdin Sillito, Helen E. Jones · 2007 · Thalamus & Related Systems
31. Retrospective Neuropsychological Profile of Patients With Parkinson Disease Prior to Developing Visual Hallucinations
    Alana J. Muller, Claire O’Callaghan, Courtney Campbell Walton, James M. Shine, Simon J.G. Lewis · 2017 · Journal of Geriatric Psychiatry and Neurology
32. The muscarinic M1 receptor modulates associative learning and memory in psychotic disorders
    Geor Bakker, Claudia Vingerhoets, Oswald Bloemen, Barbara Jacquelyn Sahakian, Jan Booij, Matthan W.A. Caan, Thérèse van Amelsvoort · 2020 · NeuroImage Clinical
33. LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization.
    Mahip K. Verma, R. Goel, Anand M. Bokare, Manoj P. Dandekar, S. Koul, Sagar Desai, Santoshkumar Tota, Nilendra Singh, Prashant B. Nigade, Vinod B. Patil et al. · 2020 · European Journal of Pharmacology
34. Nicotinic receptor modulation of the default mode network
    Britta Hahn, Alexander N. Harvey, Marta Concheiro, Marilyn Ann Huestis, Thomas J. Ross, Elliot A. Stein · 2020 · Psychopharmacology
35. Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson’s Disease
    R. Bhome, G. E. C. Thomas, A. Zarkali, R. Weil · 2023 · Current Neurology and Neuroscience Reports
36. The location of muscarinic type 2 receptors within the synaptic circuitry of the cat lateral posterior nucleus
    W. Breckinridge Carden, Martha E. Bickford · 1999 · Neuroscience Letters
37. Sleep-related hallucinations in patients with Parkinson’s disease
    Tomoko Komagamine, Keisuke Suzuki, Norito Kokubun, Junpei Komagamine, Akiko Kawasaki, Kei Funakoshi, Koichi Hirata · 2022 · PLoS ONE
38. Modes of Acetylcholine Signaling in the Prefrontal Cortex: Implications for Cholinergic Dysfunction and Disorders
    Matthew J. Fecik, Lisa M. Savage · 2023 · IntechOpen eBooks
39. Untitled work
    Waldvogel · 1999 · 10.1002/1531-8249(199907)46:1